English Intern
Lehrstuhl für klinische Epidemiologie und Biometrie

Dr. med. Martin Wagner

Phone:+ 49 (0)931 / 201 47304
Fax:+ 49 (0)931 / 201 647310
E-Mail:wagner_m(at)klinik.uni-wuerzburg.de 

kurzer Lebenslauf

2013Facharzt für Innere Medizin und Nephrologie
seit 2013PhD-fellowship "Clinical Science", Graduate School of Life Sciences, Universität Würzburg
seit 2012         Joint Appointment am Institut für Klinische Epidemiologie und Biometrie sowie in der Abteilung für Nephrologie am Universitätsklinikum Würzburg
seit 2009 Adjunct Instructor, Tufts University, Boston, MA, USA
2009Master of Science (Clinical Research), Tufts University, Boston, MA, USA: Mycophenolic Acid vs. Azathioprine as Primary Immunosuppression for Kidney Transplant Recipients: Systematic Review, Meta-Analysis, Meta-Regression
2007-2009 Fellowship in Nephrology und Sackler School of Biomedical Sciences, Tufts Medical Center/Tufts University, Boston, MA, USA
2006-2009 Assistant Project Director, "Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline: Care of the Kidney Transplant Recipient"
2005 Promotion zum Dr. med., Universitätsklinikum Würzburg: Proliferationsverhalten kultivierter Mesangialzellen und glatter Gefäßmuskelzellen nach Stimulation mit Angiotensin II und atherogenen Lipoproteinen – Rezeptorbeteiligung
2004 Approbation
seit 2003Abteilung für Nephrologie, Universitätsklinikum Würzburg
1995-2002Studium der Humanmedizin in Würzburg und Kiel

Forschungsschwerpunkte

Risiko-Evaluation von chronischen Hämodialyse-Patienten und nierentransplantierten Patienten mittels prädiktiver Modelle als Grundlage für individualisierte, risikoadaptierte Therapie

Charakterisierung der Anämie bei diabetischen Patienten mit chronischer Niereninsuffizienz

Hauptpublikationen der letzten Jahre

Wagner M, Wanner C, Schich M, Kotseva K, Wood D, Hartmann K, Fette G, Rücker V, Oezkur M, Störk S, Heuschmann PU
Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey.
BMC Nephrol. 2017 Oct 25;18(1):321. doi: 10.1186/s12882-017-0730-3.

Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Int J Behav Med. 2017 Oct 30. doi: 10.1007/s12529-017-9691-y. [Epub ahead of print]

Tiffe T, Wagner M, Rücker V, Morbach C, Gelbrich G, Störk S, Heuschmann PU
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.

Oezkur M, Magyar A, Thomas P, Stork T, Schneider R, Bening C, Störk S, Heuschmann PU, Leyh RG, Wagner M.
TIMP-2*IGFBP7 (Nephrocheck®) Measurements at Intensive Care Unit Admission After Cardiac Surgery are Predictive for Acute Kidney Injury Within 48 Hours.
Kidney Blood Press Res. 2017 Jul 27;42(3):456-467. doi: 10.1159/000479298. [Epub ahead of print]

Wagner M, Wanner C, Kotseva K, Wood D, De Bacquer D, Rydén L, Störk S, Heuschmann PU; EUROASPIRE IV investigators.
Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.
Eur J Prev Cardiol. 2017 Jan 1:2047487317708891. doi: 10.1177/2047487317708891. [Epub ahead of print]

Morbach C, Wagner M, Güntner S, Malsch C, Oezkur M, Wood D, Kotseva K, Leyh R, Ertl G, Karmann W, Heuschmann PU, Störk S.
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
BMC Cardiovasc Disord. 2017 May 5;17(1):108. doi: 10.1186/s12872-017-0543-0.

Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression - design and rationale of the STAAB cohort study.
Wagner M, Tiffe T, Morbach C, Gelbrich G, Störk S, Heuschmann PU
Eur J Prev Cardiol. 2016 Nov 22. pii: 2047487316680693. [Epub ahead of print]

Outcome of Surgical or Endovascular Treatment of Giant Intracranial Aneurysms, with Emphasis on Age, Aneurysm Location, and Unruptured Aneuryms - A Systematic Review and Meta-Analysis. Dengler J, Maldaner N, Gläsker S, Endres M, Wagner M, Malzahn U, Heuschmann PU, Vajkoczy P; Giant Intracranial Aneurysm Study Group.  Cerebrovasc Dis. 2016;41(3-4):187-98. doi: 10.1159/000443485. Epub 2016 Jan 15. PMID: 26764969

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Wagner M, Earley AK, Webster AC, Schmid CH, Balk EM, Uhlig K. Cochrane Database Syst Rev. 2015 Dec 3;12:CD007746. doi: 10.1002/14651858.CD007746.pub2. Review. PMID: 26633102 

A comparative study of a modified filtering trabeculotomy and conventional trabeculectomy. Matlach J, Hipp M, Wagner M, Heuschmann PU, Klink T, Grehn F. Clin Ophthalmol. 2015 Mar 13;9:483-92. doi: 10.2147/OPTH.S74853. eCollection 2015. PMID: 25792801

Hypertension and hypertensive cardiomyopathy in patients with a relapse-free history of phaeochromocytoma. Weismann D, Liu D, Bergen T, Peitzsch M, Raida A, Wagner M, Fassnacht M, Weidemann F, Allolio B. Clin Endocrinol (Oxf). 2015 Feb;82(2):188-96. doi: 10.1111/cen.12536. Epub 2014 Jul 25. PMID: 25040503

Activation of brown adipose tissue in hypothyroidism. Lapa C, Maya Y, Wagner M, Arias-Loza P, Werner RA, Herrmann K, Higuchi T. Ann Med. 2015 Nov;47(7):538-45. doi: 10.3109/07853890.2015.1085126. Epub 2015 Oct 29. PMID: 26513396

Vascular access choice in incident hemodialysis patients: a decision analysis. Drew DA, Lok CE, Cohen JT, Wagner M, Tangri N, Weiner DE. J Am Soc Nephrol. 2015 Jan;26(1):183-91. doi: 10.1681/ASN.2013111236. Epub 2014 Jul 25. PMID: 25063436

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease. Wagner M, Krämer J, Blohm E, Vergho D, Weidemann F, Breunig F, Wanner C. BMC Nephrol. 2014 Nov 29;15:188. doi: 10.1186/1471-2369-15-188. PMID: 25432518

Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices. Matlach J, Wagner M, Malzahn U, Göbel W. Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6536-46. doi: 10.1167/iovs.14-15072. PMID: 25228545

Chronic kidney disease, frailty, and unsuccessful aging: a review. Walker SR, Wagner M, Tangri N. J Ren Nutr. 2014 Nov;24(6):364-70. doi: 10.1053/j.jrn.2014.09.001. Epub 2014 Oct 22. Review. PMID: 25443544

M. Wagner, A. Alam, J. Zimmermann, K. Rauh, A. Koljaja-Batzner, U. Raff, C. Wanner and L. Schramm: Elevated Endogenous Erythropoietin Levels are associated with Mortality and Inflammation in Patients with Diabetes Mellitus and Chronic Kidney Disease;  Clin J Am Soc Nephrol (2011), 6: 1573–1579, 2011

M. Wagner, D. Ansell, D. M. Kent, J. L. Griffith, D. M. J. Naimark, C. Wanner, and N. Tangri: Predicting Mortality in Incident Dialysis Patients: An Analysis of the United Kingdom Renal Registry; Am J Kidney Dis (2011), 57(6):894-902

N. Tangri, M. Wagner, J. L Griffith, D. C Miskulin, A. Hodsman, D. Ansell, D. M. J. Naimark:  Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: An analysis of the United Kingdom renal registry, Am J Kidney Dis (2011), 57(3):415-421

B. L. Kasiske, M. G. Zeier, J. R. Chapman, J. C. Craig, H. Ekberg, C. A. Garvey, M. D. Green, V. Jha, M. A. Josephson, B. A. Kiberd, H. A. Kreis, R. A. McDonald, J. M. Newmann, G. T. Obrador, F. G. Vincenti, M. Cheung, A. Earley, G. Raman, S. Abariga, M. Wagner and E. M. Balk: KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary; Kidney International (2010), 77: 299–311

Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group: KDIGO clinical practice guideline for the care of kidney transplant recipients; Am J Transplant (2009), 9 Suppl 3: S1-155.

M. Wagner, E.M. Balk, D.M. Kent, B.L. Kasiske and H. Ekberg: Subgroup Analyses in Randomized Controlled Trials: the Need for Risk–Stratification in Kidney Transplantation; Am J Transplant (2009), 9: 2217-2222

M. Wagner, E.M. Balk, A.C. Webster, G. Raman, T.A. Trikalinos, C.H. Schmid and K.Uhlig;  Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients [Protocol]. Cochrane Database of Systematic Reviews.(2). 2009

S. Seibold, D. Schürle, A. Heinloth, G. Wolf, M. Wagner and J. Galle: Oxidized LDL Induces Proliferation and Hypertrophy in Human Umbilical Vein Endothelial Cells via Regulation of p27kip1 Expression: Role of RhoA; J. Am. Soc. Nephrol. (2004), 15 (12): 3026 – 3034

Kontakt

Lehrstuhl für Klinische Epidemiologie und Biometrie
Josef-Schneider-Straße 2
Haus D7
97080 Würzburg

Tel.: +49 931 201-47308
E-Mail

Suche Ansprechpartner

Medizin, Geb. D7